首页 工具
登录
购物车

搜索结果

Search Results for " erlotinib "
Targets Recommended: EGFR Autophagy

14

抑制剂 & 化合物

3

同位素标记化合物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T0373 Erlotinib

OSI-744,NSC 718781,CP358774,埃罗替尼,R1415

EGFR; Autophagy Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Erlotinib (CP358774) 是一种 EGFR 一代抑制剂,抑制 EGFR 19 Del 和 L858R 突变。Erlotinib 具有抗肿瘤活性,用于治疗 EGFR 突变的非小细胞肺癌。Erlotinib 用药会产生 EGFR C797S 耐药突变。
T6328 Desmethyl Erlotinib

OSI-420,CP-473420,O-Desmethyl Erlotinib

EGFR; Drug Metabolite Angiogenesis; JAK/STAT signaling; Metabolism; Tyrosine Kinase/Adaptors
Desmethyl Erlotinib (CP-473420) 是 Erlotinib 的活性代谢物。Erlotinib 是 EGFR 酪氨酸激酶抑制剂。
T6619 Desmethyl Erlotinib hydrochloride

OSI420,OSI-420,DesMethyl Erlotinib (CP-473420) HCl,去甲厄洛替尼,CP-473420,Desmethyl Erlotinib,OSI 420

EGFR; Drug Metabolite Angiogenesis; JAK/STAT signaling; Metabolism; Tyrosine Kinase/Adaptors
Desmethyl Erlotinib hydrochloride (OSI 420) 是 Erlotinib 的活性代谢物。Erlotinib 是 EGFR 酪氨酸激酶抑制剂。
T0373L Erlotinib hydrochloride

盐酸埃罗替尼,OSI-744,NSC 718781,Erlotinib HCl,CP-358774

EGFR; Autophagy Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Erlotinib hydrochloride (NSC 718781) 抑制EGFR 激酶的IC50为 2 nM,用于治疗非小细胞肺癌。
T0373L1 Erlotinib mesylate

CP-358774,CP-358,774,埃罗替尼甲磺酸盐,OSI-774,CP358774,OSI 774

Others Others
Erlotinib is an epidermal growth factor receptor inhibitor. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor.
T31055 CP-457493

OSI-493,Erlotinib metabolite M6,CP457493,UNII-X0JH558S7E

Others Others
CP-457493 is a bio-active chemical.
T35528 TD52

Apoptosis; Phosphatase; Akt Apoptosis; Cytoskeletal Signaling; Metabolism; PI3K/Akt/mTOR signaling
TD52 是 PP2A (CIP2A) 癌性抑制剂的口服活性抑制剂。 TD52 是厄洛替尼衍生物,通过干扰 Elk1 与 CIP2A 启动子的结合间接降低了 CIP2A。
T35528L TD52 dihydrochloride

TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl

Others Others
TD52 dihydrochloride (TD52 2HCl), a derivative of Erlotinib, is a potent and orally active inhibitor of protein phosphatase 2A (CIP2A). It exhibits strong anti-cancer properties by regulating the CIP2A/PP2A/p-Akt signaling pathway, resulting in the induction of apoptosis in triple-negative breast cancer (TNBC) cells. Mechanistically, TD52 dihydrochloride disrupts the binding of Elk1 to the CIP2A promoter, effectively reducing CIP2A levels. Notably, TD52 dihydrochloride demonstrates powerful anti...
T73472 Erasin

Others Others
Erasin 是一种有效的 Erlotinib 抗性STAT3抑制剂,对STAT3和STAT1的IC50分别为 9.7 和 24 μM。Erasin 诱导癌细胞凋亡(apoptosis)。
T34892 TM608

TM-608,TM 608

Others Others
TM608 is a potent selective c-Met inhibitor that targets mitochondria and kills erlotinib-resistant lung cancer cells, rapidly accumulates in mitochondria, and inhibits MET activation in high MET expression, erlotinib-resistant HCC827B cells (total cell l
T35147 WZ4002-hydroxy

WZ4002 analog, WZ4002 demethyl derivate,WZ 4002-hydroxy,WZ-4002-hydroxy

Others Others
WZ4002-hydroxyl is a WZ4002 derivative or WZ4002 analogue in which methoxy is replaced by hydroxyl and can be detected in 50% of patients with clinical resistance to gefitinib or erlotinib. WZ4002 has a basic chemical skeleton (covalent pyrimidine) that d
T36102 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline

Others Others
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline is a building block and synthetic intermediate.1,2,3,4,5It has been used as a precursor in the synthesis of receptor tyrosine kinase (RTK) inhibitors, dual RTK and histone deacetylase (HDAC) inhibitors, and anticancer compounds.1,2,3It is also a synthetic intermediate in the synthesis of EGFR inhibitors, including erlotinib , with antiproliferative activity.4,5
T71526 CH5164840

Others Others
CH5164840 is a potent and selective HSP90 inhibitor. CH5164840 showed remarkable antitumor activity against NSCLC cell lines and xenograft models. CH5164840 has potent antitumor activity and is highly effective in combination with erlotinib against NSCLC tumors with EGFR overexpression and mutations.
T69888 SB02024

Others Others
SB02024 is a VPS34 inhibitor. SB02024 activates cGAS-STING signaling and sensitizes tumors to STING agonist. SB02024 blocked autophagy in vitro and reduced xenograft growth of two breast cancer cell lines, MDA-MB-231 and MCF-7, in vivo. Vps34 inhibitor significantly potentiated cytotoxicity of Sunitinib and Erlotinib in MCF-7 and MDA-MB-231 in vitro in monolayer cultures and when grown as multicellular spheroids. Our data suggests that inhibition of autophagy significantly improves sensitivity...

化合物

Erlotinib
Cat.No: T0373
Synonym: OSI-744,NSC 718781,CP358774,埃罗替尼,R1415
Target: EGFR, Autophagy
Desmethyl Erlotinib
Cat.No: T6328
Synonym: OSI-420,CP-473420,O-Desmethyl Erlotinib
Target: EGFR, Drug Metabolite
Desmethyl Erlotinib hydrochloride
Cat.No: T6619
Synonym: OSI420,OSI-420,DesMethyl Erlotinib (CP-473420) HCl,去甲厄洛替尼,CP-473420,Desmethyl Erlotinib,OSI 420
Target: EGFR, Drug Metabolite
Erlotinib hydrochloride
Cat.No: T0373L
Synonym: 盐酸埃罗替尼,OSI-744,NSC 718781,Erlotinib HCl,CP-358774
Target: EGFR, Autophagy
Erlotinib mesylate
Cat.No: T0373L1
Synonym: CP-358774,CP-358,774,埃罗替尼甲磺酸盐,OSI-774,CP358774,OSI 774
Target: Others
CP-457493
Cat.No: T31055
Synonym: OSI-493,Erlotinib metabolite M6,CP457493,UNII-X0JH558S7E
Target: Others
TD52
Cat.No: T35528
Synonym:
Target: Apoptosis, Phosphatase, Akt
TD52 dihydrochloride
Cat.No: T35528L
Synonym: TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl
Target: Others
Erasin
Cat.No: T73472
Synonym:
Target: Others
TM608
Cat.No: T34892
Synonym: TM-608,TM 608
Target: Others
WZ4002-hydroxy
Cat.No: T35147
Synonym: WZ4002 analog, WZ4002 demethyl derivate,WZ 4002-hydroxy,WZ-4002-hydroxy
Target: Others
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
Cat.No: T36102
Synonym:
Target: Others
CH5164840
Cat.No: T71526
Synonym:
Target: Others
SB02024
Cat.No: T69888
Synonym:
Target: Others
Cat. No. Product Name Target Signaling Pathways
T35915 Erlotinib-13C6

Erlotinib-13C6

Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1]. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1].Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process[2]...
T19312 Erlotinib-d6 hydrochloride

CP-358774 D6 hydrochloride,NSC 718781 D6 hydrochloride,Erlotinib D6 hydrochloride,OSI-774 D6 hydrochloride

Others Others
Erlotinib Hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM. Erlotinib D6 hydrochloride a deuterium labeled Erlotinib Hydrochloride.
T11229 Erlotinib-d6

OSI-774 D6,NSC 718781 D6,CP-358774 D6

Others Others
Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib .

同位素标记化合物

Erlotinib-13C6
Cat.No: T35915
Synonym: Erlotinib-13C6
Target:
Erlotinib-d6 hydrochloride
Cat.No: T19312
Synonym: CP-358774 D6 hydrochloride,NSC 718781 D6 hydrochloride,Erlotinib D6 hydrochloride,OSI-774 D6 hydrochloride
Target: Others
Erlotinib-d6
Cat.No: T11229
Synonym: OSI-774 D6,NSC 718781 D6,CP-358774 D6
Target: Others
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼